Scientists use nanoparticle-delivered gene therapy to inhibit blinding eye disease in rodents

In experiments in rats and mice, two Johns Hopkins scientists—an engineer and an ophthalmologist—report the successful use of nanoparticles to deliver gene therapy for blinding eye disease. A uniquely engineered large molecule allows researchers to compact large bundles of therapeutic DNA to be delivered into the cells of the eye. Continue reading at Physorg